(Q54409505)

29 May 2018

title

A₃ receptors are overexpressed in pleura from patients with mesothelioma and reduce cell growth via Akt/nuclear factor-κB pathway. (English)

1 reference

29 May 2018

1 reference

1 reference

Katia Varani

1

1 reference

29 May 2018

Stefania Maniero

2

1 reference

29 May 2018

Fabrizio Vincenzi

3

1 reference

29 May 2018

Martina Targa

4

1 reference

29 May 2018

Angela Stefanelli

5

1 reference

29 May 2018

Pio Maniscalco

6

1 reference

29 May 2018

Fernanda Martini

7

1 reference

29 May 2018

Mauro Tognon

8

1 reference

29 May 2018

Pier Andrea Borea

9

1 reference

29 May 2018

language of work or name

English

0 references

publication date

24 September 2010

1 reference

29 May 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

29 May 2018

volume

183

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

522-530

1 reference

29 May 2018

Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

A molecular epidemiology case control study on pleural malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Update on the molecular biology of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

The A3 adenosine receptor: an enigmatic player in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

A3 adenosine receptor: pharmacology and role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Purinergic signalling and disorders of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

A3 adenosine receptor as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

A glance at adenosine receptors: novel target for antitumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

The A3 adenosine receptor as a new target for cancer therapy and chemoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Adenosine receptors and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Adenosine and adenosine receptors: their contribution to airway inflammation and therapeutic potential in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Asbestos-induced alveolar epithelial cell apoptosis: role of mitochondrial dysfunction caused by iron-derived free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

Apoptosis induced by crocidolite asbestos in human lung epithelial cells involves inactivation of Akt and MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0980OC

10.1164/RCCM.201006-0980OC

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

release_xiubjlscmvepnhwrfuhiwli57m

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xiubjlscmvepnhwrfuhiwli57m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

29 May 2018